Stay updated on Safety Efficacy HMI-203 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.

Latest updates to the Safety Efficacy HMI-203 in MPS II Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now uses a consolidated Locations section including California, Connecticut, New Jersey, Utah, Virginia, and Alberta, and removes the previous separate location blocks for those areas.SummaryDifference0.7%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page shows a new revision number (v3.3.2) replacing the prior v3.2.0 in the revision history. This appears to be a minor update to the page metadata without changes to study details or eligibility criteria.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the site-wide funding/operating-status notice from the page. The study details and related information remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedThe study record indicates withdrawal and discontinuation of the HMI-203 program for MPS II; the trial is no longer active.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference4%

- Check100 days agoChange Detected- Added new topics and updated revision to v3.1.0. - Removed old revision reference v3.0.2.SummaryDifference1%

Stay in the know with updates to Safety Efficacy HMI-203 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.